FEATURED NEWS
Delve’s Co-Founder Michael Wilson Featured on Encephalitis International podcast
Delve co-founder, Dr. Michael Wilson, joined Encephalitis International to discuss the difficulties in diagnosing encephalitis and how new technologies can help patients get answers faster.
Delve Neuro
Delve Neuro provides pathogen-agnostic and unbiased detection of neuro-infectious pathogens in cerebrospinal fluid (CSF) in one shot.
- Samples the entire metagenomic content – DNA and RNA – within a patient sample.
- Uses a proprietary mNGS bioinformatic pipeline to rapidly analyze millions of sequences.
- Rapidly and accurately identifies bacterial, viral, fungal, and parasitic species.
As exclusive licensee of University of California San Francisco’s (UCSF) metagenomic sequencing (mNGS) technology, Delve Bio leverages mNGS to empower labs and clinicians with the results they need to diagnose routine and rare infectious diseases.
Meet the Delve Team
Leadership
Founders
Pardis Sabeti, MD, PhD
Professor, Harvard University
Institute Member, Broad Institute
https://www.sabetilab.org
Joe DeRisi, PhD
Professor, University of California San Francisco
President, Chan Zuckerberg Biohub
https://derisilab.ucsf.edu
Matthew Meyerson, MD, PhD
Director, Center for Cancer Genomics, Dana-Farber Cancer Institute
Professor of Genetics and Medicine, Harvard Medical School
Institute Member, Cancer Program, Broad Institute
https://meyersonlab.dana-farber.org
Charles Chiu, MD, PhD
Professor, Laboratory Medicine and Medicine / Infectious Diseases, University of California, San Francisco
Associate Director, UCSF Clinical Microbiology Laboratory
Investigator, Chan-Zuckerberg Biohub
https://chiulab.ucsf.edu
Board of Directors
Investors
Perceptive Xontogeny Venture Fund II
Section 32
Google Ventures
Publications
Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis.
The New England Journal of Medicine. 2019
Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing.
The New England Journal of Medicine. 2014
Rapid Pathogen Detection by Metagenomic Next-Generation Sequencing of Infected Body Fluids.
Nat Med. 2021
Clinical metagenomics.
Nature Reviews: Genetics. 2019
Metagenomics for neurological infections — expanding our imagination.
Nature Reviews: Neurology. 2020
A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples.
Genome Research. 2014
Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and Encephalitis.
American Society for Microbiology. 2021
Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics.
Nature Communications. 2022
Unbiased Metagenomic Sequencing for Pediatric Meningitis in Bangladesh Reveals Neuroinvasive Chikungunya Virus Outbreak and Other Unrealized Pathogens
American Society for Microbiology. 2019
Metagenomic Next-Generation Sequencing for Diagnosis of Pediatric Meningitis and Encephalitis: A Review
Journal of the Pediatric Infectious Diseases Society. 2021
The Comparative Utility Of Metagenomic Next-Generation Sequencing and Universal PCR for Pathogen Detection on Cerebrospinal Fluid: A Retrospective Analysis From a Tertiary Care Center
Open Forum Infectious Diseases. 2019
Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis
Neurology Neuroimmunology & Neuroinflammation. 2023
Transmission of yellow fever vaccine virus through blood transfusion and organ transplantation in the USA in 2021: report of an investigation
The Lancet. 2023.
News and Updates
Careers
Delve has recently been made aware of a growing number of email scams targeting job candidates in the biotech industry. Delve exclusively uses @delve.bio email addresses for any and all communication. We do not ask candidates to purchase anything, nor do we ask for any sensitive information via email. If a person claiming to represent Delve with an alternative email domain reaches out to you regarding a job posting, please report it to our team by emailing support@delve.bio with details.